Previous 10 | Next 10 |
2023-04-21 03:35:00 ET Summary Water scarcity is no longer just a problem for developing countries in desert climes. As demand for water solutions grows, equity investors will find opportunities in companies that help quench the thirst of parched communities around the world with ...
2023-04-20 10:14:49 ET Shares of Life Sciences tool makers Thermo Fisher Scientific ( TMO ), Danaher Corporation ( DHR ), Repligen ( RGEN ), and Bio-Rad Laboratories ( BIO ) came under pressure after their EU peer Sartorius ( OTCPK:SARTF ) disappointed with its Q1 2023 e...
2023-04-20 03:02:03 ET Summary Danaher has a long history of beating the market. Few companies in the world have compounded their earnings like DHR over the years. I believe DHR has double-digit dividend growth potential over the long term. These days, my priority is...
2023-04-19 12:00:00 ET Summary The Akre Focus Fund invests in a small number of what we believe to be extraordinary businesses that are run by talented and honest managers who wisely reinvest free cash flow. Aftershocks from the sudden collapse and seizure of the Silicon Valley Ba...
2023-04-18 19:18:43 ET The latest barrage of earnings reports failed to move the overall stock market, as the major U.S. equity averages finished the session nearly unchanged. The S&P 500 edged up less than 0.1%. Despite the general malaise, travel stocks managed to push higher. Thi...
2023-04-17 17:51:40 ET Contract drug manufacturer Catalent (NYSE: CTLT) was surely tempted to reach for the aspirin bottle on Monday. The company's shares took a nearly 2% hit on the day (in contrast to the marginal 0.3% gain of the S&P 500 index) due to the apparent abandon...
2023-04-15 00:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Danaher Announces Conversion Date for Series B Mandatory Convertible Preferred Stock PR Newswire WASHINGTON , April 10, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its 5.00% Series B Mandatory Convertible Preferred Stock (the "Prefer...
2023-04-10 15:36:01 ET Deutsche Bank raised its recommendation for contract manufacturer Catalent ( NYSE: CTLT ) to Buy from Hold and lifted its price target to $88 from $79 per share, citing a potential upside to the company's 2023/ 2024 estimates. "The crux of our upgrade is t...
2023-04-08 10:00:31 ET Summary Carlisle beat the market by a wide margin over the last decade. The company has been transforming its business for a while and is divesting lower quality businesses. The strategy is working and the company showed an impressive operating performan...
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 10:45:04 ET Pacific Biosciences of California Inc (PACB) PACB is trading UP for the last 5 days, and it at trading at $2.10 with volume of 3,952,245 and a one day change of $0.19 (9.97%). Pacific Biosciences of California Inc has a 52-week low of 1.16 and a 52-week high o...
Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration PR Newswire BREA, Calif. , July 25, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the Dx...
2024-07-23 20:30:03 ET Goldman Sachs analyst issues NEUTRAL recommendation for DHR on July 23, 2024 06:19PM ET. The previous analyst recommendation was Neutral. DHR was trading at $264.18 at issue of the analyst recommendation. The overall analyst consensus : BUY. Cu...